UA35669A - Method for manufacturing solid dosage form of indomethacin - Google Patents

Method for manufacturing solid dosage form of indomethacin

Info

Publication number
UA35669A
UA35669A UA97010316A UA97010316A UA35669A UA 35669 A UA35669 A UA 35669A UA 97010316 A UA97010316 A UA 97010316A UA 97010316 A UA97010316 A UA 97010316A UA 35669 A UA35669 A UA 35669A
Authority
UA
Ukraine
Prior art keywords
indomethacin
mixture
dosage form
solid dosage
manufacturing solid
Prior art date
Application number
UA97010316A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Марк Вольфович Штейнгарт
Віктор Петрович Георгієвський
Виктор Петрович Георгиевский
Сергій Миколайович Третяк
Сергей Николаевич Третьяк
Вадим Олександрович Заболотний
Вадим Александрович Заболотный
Нонна Миколаївна Скакун
Нонна Николаевна Скакун
Вікторія Віталіївна Лібіна
Виктория Витальевна Либина
Ольга Всеволодівна Супрун
Ольга Всеволодовна Супрун
Ніна Євгеніївна Рудзинська
Нина Евгеньевна Рудзинская
Леонід Олександрович Чайка
Леонид Александрович Чайка
Людмила Борисівна Нельзева
Людмила Борисовна Нельзева
Original Assignee
Спільне Українсько-Естонське Підприємство Товариство З Обмеженною Відповідальністю "Юкрестінтерком Лтд"
Совместное Украинско-Эстонское Предприятие Общество С Ограниченной Ответственностью "Юкрэстинтерком Лтд"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Спільне Українсько-Естонське Підприємство Товариство З Обмеженною Відповідальністю "Юкрестінтерком Лтд", Совместное Украинско-Эстонское Предприятие Общество С Ограниченной Ответственностью "Юкрэстинтерком Лтд" filed Critical Спільне Українсько-Естонське Підприємство Товариство З Обмеженною Відповідальністю "Юкрестінтерком Лтд"
Priority to UA97010316A priority Critical patent/UA35669A/en
Publication of UA35669A publication Critical patent/UA35669A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the chemical and pharmaceutical industry and may be used for the technology of manufacturing oral Indomethacin tablets. The method for manufacturing the solid dosage form of Indomethacin comprises the preparation of the powdered mixture of Indomethacin and lactose. the moistening of the mixture, the wet granulation, the drying of the granules, the mixture of the granules with potato starch and stearate of the alkaline-earth metal, the compression of the mixture, and the coating of the cores of the tablets.
UA97010316A 1997-01-27 1997-01-27 Method for manufacturing solid dosage form of indomethacin UA35669A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA97010316A UA35669A (en) 1997-01-27 1997-01-27 Method for manufacturing solid dosage form of indomethacin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA97010316A UA35669A (en) 1997-01-27 1997-01-27 Method for manufacturing solid dosage form of indomethacin

Publications (1)

Publication Number Publication Date
UA35669A true UA35669A (en) 2001-04-16

Family

ID=74181686

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97010316A UA35669A (en) 1997-01-27 1997-01-27 Method for manufacturing solid dosage form of indomethacin

Country Status (1)

Country Link
UA (1) UA35669A (en)

Similar Documents

Publication Publication Date Title
HUP0202062A2 (en) Method for making granules with masked taste and instant release of the active particle
NZ527832A (en) Chronotherapeutic dosage forms
HUP0301302A2 (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and process for its manufacture
NZ512683A (en) Taste-masked pharmaceutical particles that are suitable for making chewable tablets
IL116674A (en) Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
MY117582A (en) Oxacarbazepine film-coated tablets
HK1019858A1 (en) Process for forming solid oral dosage forms of valsartan.
HK1046620A1 (en) Process for manufacturing a pharmaceutical chewinggum
WO1997038679A3 (en) Fast disintegrating oral dosage form
EE200100260A (en) A method for preparing an oral calcium composition, a granulate and a tablet
CA2427815A1 (en) Controlled release hydrocodone formulations
HUP0103567A2 (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same
HK1045519A1 (en) 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7)receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds.
HUP0101281A3 (en) Diphenyl-piperidine butanamides as glycine transport inhibitors, process for producing them, use of them for producing medicaments and the pharmaceutical compositions containing them
WO2002043700A3 (en) Particles for use in a pharmaceutical composition
CA2273325A1 (en) Coated detergent tablet
CA2272442A1 (en) Lozenge for the modified releasing of active substances in the gastrointestinal tract
NZ336592A (en) Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier
MXPA03007635A (en) P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same.
IL150528A0 (en) Ibuprofen containing active agent preparation
AU1434700A (en) Dry powder pharmaceutical formulation
AU7201298A (en) Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
DE3173600D1 (en) Spray dried n-acetyl-p-aminophenol compositions and method for manufacture thereof
UA35669A (en) Method for manufacturing solid dosage form of indomethacin
HUP9801879A3 (en) Pyridazinone-derivatives as endothelin-receptor antagonists, use thereof, pharmaceutical compositions containing these compounds and process for the preparation of the compounds and the compositions